Vitality Biopharma Files Intellectual Property in All Major Pharmaceutical Markets Worldwide

THC prodrugs including VBX-100 designed to deliver cannabinoids for targeted therapeutic effects without psychoactivity LOS ANGELES, March 28, 2018 (GLOBE NEWSWIRE)  Vitality Biopharma, Inc. (OTCQB:VBIO) (“Vitality” or the “Company”) a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced the filing of its cannabosides intellectual property (Publ. No. WO2017053574 A1) in all major pharmaceutical markets worldwide. After initial submission through the Patent Cooperation The post Vitality Biopharma Files Intellectual Property in All Major Pharmaceutical Markets Worldwide appeared first on Public Wire.
http://bit.ly/2uoqZh2